Disruptions in the cytochrome P450-soluble epoxide hydrolase (CYP450-sEH) pathway have been reported in T2DM, obesity and cognitive impairment. The gene discussed is EPHX2; the disease is obesity due to melanocortin 4 receptor deficiency.